Field operations in FDA’s human drugs program would bear the brunt of the reductions included in the agency’s fiscal year 2016 budget request.
FDA Field Operations Would Endure Reductions Under Budget
President Obama’s FY 2016 blueprint includes cuts to ‘low-priority’ enforcement, surveillance and other activities in FDA human drugs and biologics programs, but still increases those operations overall.